Inventor · disambiguated record
Karsten Juhl
Also filed as: JUHL KARSTEN
53 granted patents·14 pending applications·197 citations·filing 2004–2024
98Inventor score
Top patents by PatentIndex Score
67 records- 0197US11026923B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Jun 8, 2021·4 cites·17 claims
- 0297US11026924B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Jun 8, 2021·4 cites·19 claims
- 0396US10351561B2Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 16, 2019·12 cites·21 claims
- 0495US11111290B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Sep 7, 2021·6 cites·9 claims
- 0595US10806718B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Oct 20, 2020·7 cites·16 claims
- 0694US10034861B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jul 31, 2018·13 cites·28 claims
- 0794US9346797B12-amino 6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitorsLUNDBECK & CO AS H·Filed 2015·Granted May 24, 2016·7 cites·19 claims
- 0893US11491140B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Nov 8, 2022·2 cites·20 claims
- 0993US10689379B2Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Jun 23, 2020·6 cites·14 claims
- 1093US10618913B2Macrocycles as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Apr 14, 2020·7 cites·19 claims
- 1193US10512632B21 H-pyrazolo[4,3-B]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Dec 24, 2019·9 cites·13 claims
- 1292US10647762B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted May 12, 2020·5 cites·3 claims
- 1391US10766893B21H-pyrazolo[4,3-b]pyridines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Sep 8, 2020·6 cites·19 claims
- 1491US9533992B2PDE9 inhibitors with imidazo triazinone backboneH LUNDBECK AS·Filed 2016·Granted Jan 3, 2017·10 cites·9 claims
- 1590US9353084B22-amino 3,5,5-trifluoro-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treatment of Alzheimer's diseaseLUNDBECK & CO AS H·Filed 2015·Granted May 31, 2016·9 cites·22 claims
- 1689US10487142B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2019·Granted Nov 26, 2019·5 cites·3 claims
- 1788US10538525B21,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Jan 21, 2020·5 cites·15 claims
- 1888US10472415B2Antibodies specific for hyperphosphorylated tau and methods of useH LUNDBECK AS·Filed 2017·Granted Nov 12, 2019·5 cites·3 claims
- 1988US2025257124A1Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2024·Application pending·0 cites
- 2087US9850249B2PDE9 inhibitors with imidazo triazinone backboneH LUNDBECK AS·Filed 2016·Granted Dec 26, 2017·6 cites·5 claims
- 2186US10858362B2Imidazopyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Dec 8, 2020·2 cites·12 claims
- 2286US8420667B2Isoquinolinone derivatives as NK3 antagonistsKHANZHIN NIKOLAY·Filed 2009·Granted Apr 16, 2013·13 cites·14 claims
- 2385US11104680B21,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 inhibitorsH LUNDBECK AS·Filed 2019·Granted Aug 31, 2021·1 cites·15 claims
- 2485US10905688B2Combinations comprising substituted imidazo[1,5-α]pyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Feb 2, 2021·2 cites·22 claims
- 2585US9643970B2Substituted imidazo [1,5-a]pyrazines as PDE9 inhibitorsH LUNDBECK AS·Filed 2012·Granted May 9, 2017·8 cites·10 claims
- 2685US9434733B2PDE9 inhibitors with imidazo triazinone backboneH LUNDBECK AS·Filed 2013·Granted Sep 6, 2016·7 cites·4 claims
- 2782US9993477B2Substituted imidazo[1,5-a]pyrazines as PDE9 inhibitorsH LUNDBECK AS·Filed 2017·Granted Jun 12, 2018·3 cites·6 claims
- 2882US8173639B2Isoquinolinone derivatives as NK3 antagonistsSIMONSEN KLAUS BAEK·Filed 2008·Granted May 8, 2012·12 cites·48 claims
- 2978US12129289B2Antibodies specific for hyperphosphorylated tau and methods of use thereofH LUNDBECK AS·Filed 2021·Granted Oct 29, 2024·0 cites·15 claims
- 3078US10633382B2Imidazopyrazinones, pyrazolopyrimidinones and pyrazolopyridinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Apr 28, 2020·2 cites·32 claims
- 3178US10045974B22-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitorsH LUNDBECK AS·Filed 2015·Granted Aug 14, 2018·1 cites·3 claims
- 3277US10912773B2Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2017·Granted Feb 9, 2021·2 cites·22 claims
- 3374US7563908B22-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIKEHLER JAN·Filed 2005·Granted Jul 21, 2009·2 cites·15 claims
- 3473US7678800B22-(1H-indolylsulfanyl)-aryl amine derivatives for use in the treatment of affective disorders, pain, ADHD and stress urinary incontinenceLUNDBECK & CO AS H·Filed 2005·Granted Mar 16, 2010·2 cites·29 claims
- 3573US2020375950A11h-pyrazolo[4,3-b]pyridines as pde1 inhibitorsH LUNDBECK AS·Filed 2020·Application pending·0 cites
- 3672US11535611B2Pyrazolo[3,4-B]pyridines and imidazo[1,5-B]pyridazines as PDE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Dec 27, 2022·1 cites·9 claims
- 3772US10603310B22-amino-6-(difluoromethyl)-5,5-difluoro-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitorsH LUNDBECK AS·Filed 2018·Granted Mar 31, 2020·0 cites·3 claims
- 3872US7737170B2Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRISLUNDBECK & CO AS H·Filed 2008·Granted Jun 15, 2010·1 cites·2 claims
- 3972US7737171B2Uses of 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRISLUNDBECK & CO AS H·Filed 2008·Granted Jun 15, 2010·1 cites·2 claims
- 4072US7652150B22-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRIsLUNDBECK & CO AS H·Filed 2008·Granted Jan 26, 2010·1 cites·19 claims
- 4171US10011596B22-amino-3-fluoro-3-(fluoromethyl)-6-methyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitorsH LUNDBECK AS·Filed 2016·Granted Jul 3, 2018·1 cites·31 claims
- 4270US11472810B2Imidazopyrazinones as PDE1 inhibitorsH LUNDBECK AS·Filed 2020·Granted Oct 18, 2022·0 cites·18 claims
- 4370US10004738B2Combination treatment comprising administration of 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahydropyridinesH LUNDBECK AS·Filed 2016·Granted Jun 26, 2018·1 cites·22 claims
- 4469US10059669B22-amino-3,5-difluoro-3,6-dimethyl-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitors for treating alzheimer's diseaseH LUNDBECK AS·Filed 2015·Granted Aug 28, 2018·1 cites·18 claims
- 4569US10058540B22-amino-5,5-difluoro-6-(fluoromethyl)-6-phenyl-3,4,5,6-tetrahydropyridines as BACE1 inhibitorsH LUNDBECK AS·Filed 2015·Granted Aug 28, 2018·1 cites·15 claims
- 4669US8415356B2Isoquinolinone derivatives as NK3 antagonistsKHANZHIN NIKOLAY·Filed 2009·Granted Apr 9, 2013·1 cites·23 claims
- 4769US8415373B2Isoquinolinone derivatives as NK3 antagonistsKHANZHIN NIKOLAY·Filed 2009·Granted Apr 9, 2013·1 cites·20 claims
- 4869US8242134B2Isoquinolinone derivatives as NK3 antagonistsKHANZHIN NIKOLAY·Filed 2009·Granted Aug 14, 2012·1 cites·31 claims
- 4966US8207347B2Pyridone derivatives as NK3 antagonistsKHANZHIN NIKOLAY·Filed 2010·Granted Jun 26, 2012·1 cites·20 claims
- 5062US2024425521A1Spiromacrocyclic orexin 2 receptor agonistsH LUNDBECK AS·Filed 2024·Application pending·0 cites
Showing the top 50 of 67 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Karsten Juhl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →